AbbVie Stock News

If you're looking for attractive dividend-paying stocks, that's a smart move. If you're not, perhaps reconsider -- because:

2024 is going out with a bang as mystery drones, Federal Reserve hawkishness, and quantum stocks dominate headlines. It's time to look towards 2025 after another banner year for stocks. Here are four stocks in timely, tremendous industries to keep on your radar.

With its shares offering a total return of nearly 49% over the last three years, trumping the market's return of 33%, AbbVie (ABBV 2.37%) is a powerhouse big pharma that has a lot of upside to offer to investors.

AbbVie (ABBV 2.37%) and Amgen (AMGN 0.84%) have a lot in common. They are both leading drugmakers and have strong dividend track records.

Stock market investors have plenty of reasons to celebrate as 2024 comes to a close. The S&P 500 index set multiple new record highs during the year, delivering a spectacular 25% return year to date amid a resilient economy and strong corporate earnings.

The methodology uses earnings yield, dividend yield, and 5-year dividend CAGR to score and rank 55 stocks across all 11 sectors. Stocks with no dividends are excluded, ensuring a focus on dividend growth, momentum, and value. The top stocks by sector are evaluated and then backtested in an equal weight format.

Santa Claus will soon be on his way delivering presents to kids around the world. But could the jolly gift-giver bring something for investors, too?

Dividend investing can provide reliable income and peace of mind in retirement. I share five standout picks perfect for a retirement-ready portfolio. These stocks offer strong yields, consistent growth, and robust fundamentals, making them ideal for retirees seeking steady cash flow and stability. Whether you're planning for retirement or already there, these dividend gems combine reliability a...